A modular transcriptome map of mature B cell lymphomas

[1]  Ryan D. Morin,et al.  Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. Barrans,et al.  Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Stefano Monti,et al.  Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes , 2018, Nature Medicine.

[4]  Roland Schmitz,et al.  Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma , 2018, The New England journal of medicine.

[5]  R. Spang,et al.  Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2 , 2018, Haematologica.

[6]  C. Beham‐Schmid.  Aggressive lymphoma 2016: revision of the WHO classification , 2017, memo - Magazine of European Medical Oncology.

[7]  D. Dunson,et al.  Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma , 2017, Cell.

[8]  Steve Hoffmann,et al.  Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome , 2017, The Journal of pathology.

[9]  H. Binder,et al.  Multilineage communication regulates human liver bud development from pluripotency , 2017, Nature.

[10]  Dirk Schadendorf,et al.  Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq , 2016, Oncotarget.

[11]  E. Giné,et al.  Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage. , 2016, Cancer cell.

[12]  Hans Binder,et al.  oposSOM: R-package for high-dimensional portraying of genome-wide expression landscapes on bioconductor , 2015, Bioinform..

[13]  Ash A. Alizadeh,et al.  Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .

[14]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[15]  Ash A. Alizadeh,et al.  Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation , 2015, Proceedings of the National Academy of Sciences.

[16]  Hans Binder,et al.  Personalized Disease Phenotypes from Massive OMICs Data , 2015 .

[17]  O. O’Connor,et al.  Putting the Clinical and Biological Heterogeneity of Non-Hodgkin Lymphoma into Context , 2014, Clinical Cancer Research.

[18]  Arsen Arakelyan,et al.  Gene Set- and Pathway- Centered Knowledge Discovery Assigns Transcriptional Activation Patterns in Brain, Blood, and Colon Cancer: A Bioinformatics Perspective , 2014, Int. J. Knowl. Discov. Bioinform..

[19]  A. Melnick,et al.  Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis. , 2014, Trends in molecular medicine.

[20]  R. Spang,et al.  A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. , 2014, Blood.

[21]  Raul Rabadan,et al.  Genetics of follicular lymphoma transformation. , 2014, Cell reports.

[22]  A. McKenna,et al.  Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. , 2014, Cancer cell.

[23]  M. Calaminici,et al.  Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma , 2013, Nature Genetics.

[24]  Hans Binder,et al.  Analysis of Large-Scale OMIC Data Using Self Organizing Maps , 2014 .

[25]  A. Rosenwald,et al.  Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. , 2013, Hematology. American Society of Hematology. Education Program.

[26]  Hans Binder,et al.  Portraying the Expression Landscapes of B-Cell Lymphoma-Intuitive Detection of Outlier Samples and of Molecular Subtypes , 2013, Biology.

[27]  M. Kaminski,et al.  Recurrent STAT6 Mutations In Follicular Lymphoma , 2013 .

[28]  W. Klapper,et al.  Massive Transcriptional Perturbation in Subgroups of Diffuse Large B-Cell Lymphomas , 2013, PloS one.

[29]  G. Botti,et al.  MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas , 2013, Infectious Agents and Cancer.

[30]  R. Spang,et al.  Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens. , 2013, Blood.

[31]  Mario Fasold,et al.  Portraying the expression landscapes of cancer subtypes , 2013 .

[32]  David Dunson,et al.  Genetic heterogeneity of diffuse large B-cell lymphoma , 2013, Proceedings of the National Academy of Sciences.

[33]  Ash A. Alizadeh,et al.  Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. , 2012, Blood.

[34]  E. Campo.  New pathogenic mechanisms in Burkitt lymphoma , 2012, Nature Genetics.

[35]  R. Spang,et al.  Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing , 2012, Nature Genetics.

[36]  Michael R. Green,et al.  Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. , 2012, Cancer cell.

[37]  L. Staudt,et al.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics , 2012, Nature.

[38]  M. Nussenzweig,et al.  Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. , 2012, Blood.

[39]  P. Murray,et al.  BLIMP1α, the master regulator of plasma cell differentiation is a tumor supressor gene in B cell lymphomas. , 2012, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[40]  R. Spang,et al.  Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. , 2012, Blood.

[41]  P. Murray,et al.  BLIMP 1 α , THE MASTER REGULATOR OF PLASMA CELL DIFFERENTIATION IS A TUMOR SUPRESSOR GENE IN B CELL LYMPHOMAS , 2012 .

[42]  Martin von Bergen,et al.  Mining SOM expression portraits: feature selection and integrating concepts of molecular function , 2011, BioData Mining.

[43]  Dirk Hasenclever,et al.  Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. , 2011, Blood.

[44]  Martin von Bergen,et al.  Expression cartography of human tissues using self organizing maps , 2011, BMC Bioinformatics.

[45]  I. Lossos,et al.  Transformation of follicular lymphoma. , 2011, Best practice & research. Clinical haematology.

[46]  Elias Campo,et al.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. , 2011, Blood.

[47]  L. Pasqualucci,et al.  Molecular pathogenesis of diffuse large B-cell lymphoma. , 2011, Seminars in diagnostic pathology.

[48]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[49]  Philip M Kluin,et al.  Double-hit B-cell lymphomas. , 2011, Blood.

[50]  Raul Rabadan,et al.  Inactivating mutations of acetyltransferase genes in B-cell lymphoma , 2010, Nature.

[51]  H. Drexler.  Establishment and culture of leukemia-lymphoma cell lines. , 2011, Methods in molecular biology.

[52]  R. Spang,et al.  Translocations activating IRF 4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults * , 2011 .

[53]  Govind Bhagat,et al.  BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. , 2010, Cancer cell.

[54]  Babak Shahbaba,et al.  A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients. , 2009, Blood.

[55]  Liisa Holm,et al.  Robust extraction of functional signals from gene set analysis using a generalized threshold free scoring function , 2009, BMC Bioinformatics.

[56]  L. Staudt,et al.  Stromal gene signatures in large-B-cell lymphomas. , 2008, The New England journal of medicine.

[57]  R. Spang,et al.  Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. , 2008, Blood.

[58]  R. Spang,et al.  Pathway activation patterns in diffuse large B-cell lymphomas , 2008, Leukemia.

[59]  Ilya Shmulevich,et al.  ProbCD: enrichment analysis accounting for categorization uncertainty , 2007, BMC Bioinformatics.

[60]  G. Salles.  Clinical features, prognosis and treatment of follicular lymphoma. , 2007, Hematology. American Society of Hematology. Education Program.

[61]  R. Spang,et al.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.

[62]  Stefano Monti,et al.  Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma , 2006, The Journal of experimental medicine.

[63]  R. Rosenquist,et al.  Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis , 2005, Modern Pathology.

[64]  Bing Zhang,et al.  WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..

[65]  Ralf Küppers,et al.  Mechanisms of B-cell lymphoma pathogenesis , 2005, Nature Reviews Cancer.

[66]  T. Golub,et al.  Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. , 2004, Blood.

[67]  L. Staudt,et al.  The biology of human lymphoid malignancies revealed by gene expression profiling. , 2005, Advances in immunology.

[68]  Prof. Dr. med. Alfred Christian Feller,et al.  Histopathology of Nodal and Extranodal Non-Hodgkin’s Lymphomas , 2012, Springer Berlin Heidelberg.

[69]  Jerry Radich,et al.  Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood. , 2004, Blood.

[70]  L. Staudt,et al.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.

[71]  S. Pileri,et al.  Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases , 2003, Journal of clinical pathology.

[72]  Adrian Wiestner,et al.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[73]  K. Tarte,et al.  Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. , 2003, Blood.

[74]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[75]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[76]  Hans G. Drexler,et al.  The Leukemia-Lymphoma Cell Line Factsbook , 2000 .

[77]  Ramakrishnan Srikant,et al.  Fast Algorithms for Mining Association Rules in Large Databases , 1994, VLDB.

[78]  Prof. Dr. Dr. h.c. mult. Karl Lennert,et al.  Histopathology of Non-Hodgkin’s Lymphomas , 1992, Springer Berlin Heidelberg.

[79]  S Mori,et al.  [Histopathology of non-Hodgkin's lymphomas]. , 1985, Rinsho hoshasen. Clinical radiography.